HOFTREX

This brand name is authorized in Nigeria.

Active ingredients

The drug HOFTREX contains one active pharmaceutical ingredient (API):

1
UNII 023Z5BR09K - CEFTRIAXONE SODIUM
 

Ceftriaxone is an antibacterial for systemic use, a third-generation cephalosporin. It inhibits bacterial cell wall synthesis following attachment to penicillin binding proteins (PBPs) leading to bacterial cell lysis and death.

 
Read more about Ceftriaxone

Packages

This drug has been approved in Nigeria as follows:

Identifier Form Presentation Description Approval
A4-5694 Powder for solution for injection/infusion Hoftrex Injection INJ_PWD_F_SOL 1 g 1 X 1 VIAL + 10ML WFI Powder for injection in a labelled vial containing ceftriazone and sterile water for dilution. 28/04/2022

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
J01DD04 Ceftriaxone J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DD Third-generation cephalosporins
Discover more medicines within J01DD04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
NG Registered Drug Product Database A4-5694

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.